Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability

Stanford University

Status: Invitation-only

Conditions: Metabolic Diseases; Infertility

Treatments: Procedure: Improving the scientific process of human cell reprogramming

Study type: Observational

Funder types: Other

Identifiers

NCT00628199

NCT00553826

SU-12202007-950

Details and patient eligibility

About

This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.

Full description

It is thought that studies of genetic reprogramming and SCNT using human cells have the potential to give us new basic knowledge about human development. Current work will focus on developing this basic knowledge. In the future, human embryonic stem cell lines (hESC) derived from genetic reprogramming and SCNT may also have the potential to develop into cell types that are useful for cell-based therapies to treat human disease and disability.

Enrollment: 60 estimated patients

Sex: All

Ages: 1 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:1. Donors with a degenerative disease phenotype or genetic disorders such as Type I Diabetes, heart disease, or infertility (azoospermia and premature ovarian failure)

Exclusion Criteria:1. Unable to read or understand English. 2. Unable to provide skin biopsy sample due to skin condition in the underarm area.